Vanda Pharmaceuticals, Inc. (VNDA) Reports Third Quarter 2012 Results  
11/8/2012 9:45:47 AM

WASHINGTON, Nov. 7, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2012.